Wei Jiang, Wenjie Yang, Ping Liu, Na Wang, Haixia Ren, Xuequn Zhao
Department of Infectious Disease, Tianjin First Center Hospital, Tianjin 300192, P.R. China.
Laboratory of Microbiology of Tianjin First Center Hospital, Tianjin 300192, P.R. China.
Exp Ther Med. 2018 Mar;15(3):2247-2254. doi: 10.3892/etm.2018.5728. Epub 2018 Jan 9.
Overuse and misuse of antibiotics leads to rapid evolution of antibiotic-resistant bacteria and antibiotic resistance genes. has become the most common pathogenic bacterium accountable for nosocomial infections due to its high virulence factor and general occurrence of resistance to most antibiotics. The β-lactamase signaling pathway has been suggested to be involved in antibiotic resistance against β-lactams in . In the present study, the molecular mechanism of the antibiotic resistance of was investigated and the results indicated involvement of the β-arrestin recruitment-induced β-lactamase signaling pathway. Antimicrobial susceptibility of was assessed using automated systems and extended-spectrum β-lactamase (ESBL) and β-arrestin expression levels in were analyzed by reverse-transcription quantitative PCR. β-lactam resistance in was determined using β-lactam agar screening plates. The results demonstrated that β-arrestin recruitment was increased in with antibiotic resistance (AR-.) compared with that in the native strain (NB-.). Increased production of ESBL was observed in AR-. after treatment with the β-lactam penicillin. Of note, inhibition of β-arrestin recruitment significantly suppressed ESBL expression in AR-. and in addition, genes encoding β-arrestin and ESBL were upregulated in . Restoration of endogenous β-arrestin markedly increased antibiotic resistance of to β-lactam. Knockdown of endogenous β-arrestin downregulated antibiotic resistance genes and promoted the inhibitory effects of β-lactam antibiotic treatment on growth. In conclusion, the present study identified that β-arrestin recruitment was associated with growth and resistance to β-lactams, which suggested that β-arrestin regulating ESBL expression may be a potential target for addressing antibiotic resistance to β-lactams in .
抗生素的过度使用和滥用导致了抗生素耐药细菌和抗生素耐药基因的快速进化。由于其高毒力因子以及对大多数抗生素普遍存在耐药性,已成为医院感染中最常见的病原菌。β-内酰胺酶信号通路被认为与该菌对β-内酰胺类抗生素的耐药性有关。在本研究中,对该菌抗生素耐药性的分子机制进行了研究,结果表明β-抑制蛋白募集诱导的β-内酰胺酶信号通路参与其中。使用自动化系统评估该菌的抗菌药敏性,并通过逆转录定量PCR分析该菌中广谱β-内酰胺酶(ESBL)和β-抑制蛋白的表达水平。使用β-内酰胺琼脂筛选平板测定该菌对β-内酰胺类抗生素的耐药性。结果表明,与天然菌株(NB-)相比,具有抗生素耐药性的该菌(AR-)中β-抑制蛋白的募集增加。在用β-内酰胺类青霉素治疗后,AR-中观察到ESBL产量增加。值得注意的是,抑制β-抑制蛋白募集可显著抑制AR-中ESBL的表达,此外,该菌中编码β-抑制蛋白和ESBL的基因上调。内源性β-抑制蛋白的恢复显著增加了该菌对β-内酰胺类抗生素的耐药性。内源性β-抑制蛋白的敲低下调了抗生素耐药基因,并增强了β-内酰胺类抗生素治疗对该菌生长的抑制作用。总之,本研究发现β-抑制蛋白募集与该菌的生长及对β-内酰胺类抗生素的耐药性相关,这表明β-抑制蛋白调节ESBL表达可能是解决该菌对β-内酰胺类抗生素耐药性的一个潜在靶点。